Introduction
consitutively expressed by the vascular endothelium, platelets, kidneys, and elsewhere. 11 In addition, a cySeveral lines of evidence implicate immune and in-tokine-inducible cyclo-oxygenase, COX-2, has been flammatory mechanisms in the pathogenesis of athero-detected in several different cell types.
12-14 The exsclerosis. Human atherosclerotic plaques contain large pression of COX-2 is restricted under basal conditions numbers of macrophages and also significant amounts and upregulated during inflammation, e.g. in rheumof T lymphocytes, many of which are in an activated atoid arthritis. 15 Expression of COX-2 in human umstate. [1] [2] [3] Activated immune cells secrete a host of cyto-bilical vein endothelial cells is stimulated by kines, which regulate gene expression in other cells of inflammatory mediators like tumour necrosis factorthe plaque by paracrine action. 4 In atherosclerosis, interleukin-1 16 and by hypoxia. 17 This provides a much interest has been focused on cytokine-regulated synthetic pathway for eicosanoids which is regulated expression of metalloproteinases, 5 MHC genes, 6 actins 7 in an entirely different way from the constitutive one and collagens 8 and its possible role in the progression and directly lined to inflammation. 18 of atherosclerosis 4 and the development of acute corAcetylsalicylic acid (ASA), an inhibitor of both COXonary syndromes. 9 1 and COX-2, has been used for several years as In addition to cytokines and growth factors, non-primary and secondary prophylactic drugs in cardioprotein mediators also play pivotal roles in the re-vascular disease. 19 The beneficial effect of ASA -a gulation of vascular function. For instance, prosta-traditional anti-inflammatory drug -has previously glandins E2 (PGE 2 ) and PGI 2 are important modulators been linked to its effects on platelets. 20 Inhibition of of lipid metabolism, vascular cell proliferation, and cyclo-oxygenases in platelets by ASA blocks the pathplatelet aggregation.
10 They are normally produced way leading to thromboxane formation and platelet by the enzyme cyclo-oxygenase-1 (COX-1), which is aggregation is thus prevented. Recent evidence suggests that the preventive effect of ASA in cardio- * Please address all correspondence to: V. Stemme, Cardiovascular vascular disease may also be linked to its anti-Since inflammation is an integral part of athero-GmbH, Mannheim, Germany) in 30 cycles of 94°C for 1 min, 58°C for 1 min, 72°C for 1 min, and after the sclerosis and the preventive effect of ASA may, at least partially, be due to its anti-inflammatory effect, it is last cycle a 10 min elongation step at 72°C. The PCRproducts were then visualised in ethidium-bromide of interest to establish whether COX-2 is present in atherosclerotic lesions. In the present study we ana-stained 1.5% agarose gels, using a 100 bp DNA ladder (Gibco BRL, Life Technologies, Gaithersburg, MD, lyzed the expression of COX-1 and COX-2, mRNA and protein, in human carotid atherosclerotic arteries U.S.A.) as a size marker.
The following primers were used: 24 and in non-atherosclerotic mammary arteries and saphenous veins. COX-1: 5′-CCT ACA CCT CCT TCC AGG AGC TC-3′ 5′-AGA CCA GCT TCT TCA GTG TGG CCG-3′ COX-2: 5′-TTC AAA TGA GAT TGT GGG AAA ATT GCT-3′ Materials and Methods 5′-AGA TCA TCT CTG CCT GAG TAT CTT-3′
Vascular biopsies Immunohistochemistry Specimens from atherosclerotic carotid arteries were obtained from symptomatic patients undergoing ca-The tissue sections were fixed for 5 min in acetone in rotid endarterectomy. Specimens from non-athero-room temperature, rinsed in PBS and air-dried. The sclerotic arteries (mammary artery) and veins sections were preincubated in 5% Normal Goat Serum (saphenous vein) were obtained from patients under-(NGS) and 2% dry milk powder at room temperature going coronary bypass surgery. The tissue biopsies for 30 min. Incubation with primary antibodies in 1% were divided in two to four pieces. Samples for bovine serum albumin (BSA, Sigma Chemical Co, St. immunohistochemistry were embedded in Tissue-Tek Louis, MO, U.S.A.) and 2% dry milk powder were O.C.T. Compound (Miles Inc. Diagnostics Division, performed at 4°C over night. The optimal conElkhart, IN, U.S.A.), snap frozen in liquid nitrogen and centration for each antibody was established by serial stored at −80°C. Cryostat sections from the vascular dilution experiments on carotid endarterectomy specibiopsies were cut and mounted on SuperFrost  Plus mens and on cultured human macrophages stimulated glass slides (Menzel-Gläser, Germany) and sections by lipopolysaccharide. After rinsing with PBS, the stored at −80°C. For RNA extraction, tissue specimens sections were incubated with secondary antibodies in were frozen immediately in liquid nitrogen and stored 1% BSA and 2% dry milk powder at room temperature at −80°C.
for 30 min. After incubation with ABC-AP (AvidinBiotin Complex Alkaline Phosphatase, Vector Laboratories, Burlingame, CA, U.S.A.) or PAP (Peroxidase Anti-Peroxidase, DAKO A/S, Glostrup, Denmark)
RNA-extraction and RT-PCR
staining procedures were performed with alkaline phosphatase (Alkaline Phosphatase Substrate Kit, Vec-RNA-isolation from the tissue biopsies was performed tor Laboratories) or peroxidase (Peroxidase Substrate using ULTRASPEC TM RNA isolation system (Biotecx Kit, Vector Laboratories) according to the manuLaboratories, Inc., Houston, TX, U.S.A.) and the RNA-facturer's instructions. The sections were countersamples were then analysed by reverse transcriptase stained with Haematoxylin Harris stain solution at polymerase chain reaction (RT-PCR) technique. 22, 23 room temperature for 15 s (Histolab Products AB, cDNA synthesis was performed from 1 g total RNA Gö teborg, Sweden). Microphotographs were taken per sample in 20 l of 50 mM Tris-HCl, pH 8.3, 75 mM using a Leica DMRB microscope with a WILD MPS48 KCl, 3 mm MgCl 2 , 50 pmol pd(N) 6 (Pharmacia Biotech, photo unit (Leica Mikroskopie und Systeme GmbH, Uppsala, Sweden), 1 mM dNTP, 10 mm dithiothreitol Wetzlar, Germany). The film used was Kodak GOLD, Immunohistochemistry analysis showed that COX-2 as well as COX-1 proteins were expressed in sections from atherosclerotic arteries. Ten plaques from different patients were analysed. COX-2 was detected in macrophages as revealed by double-staining using anti-COX-2 together with the macrophage-specific marker, CD68 (Fig. 2) . COX-2 was particularly abundant in macrophages in and close to the necrotic parts of the atherosclerotic lesion. Using anti-COX-2 together with anti-von Willebrand factor, we also detected COX- (Fig. 2) . Finally, staining for PCR-products for COX-2.
COX-2 could be detected in some SM -actin positive smooth muscle cells in the thickened intima and in and anti-COX-2 (polyclonal rabbit anti-human COXthe media under the plaque (Fig. 2) . 2) was kindly provided by A. W. Ford-Hutchinson, Merck Frost Centre for Therapeutic Research (Quebec, Canada). The antibodies have approximately 1000-fold selectivity for COX-1 and COX-2 respectively. 25 
Anti-SM -actin (to identify smooth muscle cells): Cyclo-oxygenase expression in non-atherosclerotic vessels monoclonal mouse anti-human SM -actin (DAKO A/ S).
The expression of COX-2 and COX-1 in human mamAnti-von Willebrand Factor (to identify endothelial mary arteries, with no macroscopic signs of atherocells): monoclonal mouse anti-human von Willebrand sclerosis, and in saphenous veins was examined by Factor (DAKO A/S).
RT-PCR and immunohistochemistry. COX-2 mRNA Anti-CD 68 (to identify macrophages): monoclonal was detected in four out of five mammary arteries mouse anti-human CD 68 (DAKO A/S). and in four of four saphenous veins (Fig. 3) . COX-1 As secondary antibodies we used: (i) biotinylated mRNA was detected in all analysed mammary arteries goat anti-rabbit (Vector Laboratories) for polyclonal and saphenous veins (Fig. 3) . primary antibodies and (ii) rabbit anti-mouse immunoIn both the mammary arteries (Fig. 4) and the saglobulins (DAKO A/S) for monoclonal primary anti-phenous veins (data not shown), COX-2 protein was bodies.
detected in the vasa vasorum in the adventitia by immunohistochemistry. Sparse staining for COX-2 was also detected in some parts of the endothelium (data not shown). COX-1 protein was detected in the luminal Results endothelium in the mammary arteries (Fig. 4) as well as in the saphenous veins (data not shown). Specimens of human vascular tissue were collected at surgery and immediately prepared for analysis. Atherosclerotic plaques were obtained from carotid arteries at endarterectomy and normal mammary arteries and saphenous veins at coronary bypass surgery. Discussion Gene expression was analysed on the mRNA level using PCR after reverse transcription into cDNA (RT-In the present study we report the expression of COX-PCR) and on the protein level by immuno-2 in atherosclerotic lesions. The presence of COX-2 has histochemistry.
been described in other conditions in which inflammation is part of the pathological process, e.g. in synovial tissue in rheumatoid arthritis. 26 Under physiological conditions, COX-1 catalyses the rateCyclo-oxygenase expression in atherosclerotic arteries limiting step in the synthesis of prostaglandins, e.g. PGI 2 in the endothelium, leading to vasodilatation and RT-PCR analysis demonstrated expression of COX-2 mRNA in all (nine) atherosclerotic arteries, while COX-counteracting platelet aggregation. A protective role has been proposed for COX-2, by mediating release 1 mRNA was detected in four of nine (Fig. 1) . of PGI 2 , in conditions where the endothelium is dam-COX-2 has been found in activated smooth muscle cells after vascular injury in rat arteries, 28 indicating a aged or dysfunctional. 27 On the other hand, prostaglandins also mediate inflammatory reactions. The role for COX-2 in the development of intimal hyperplasia. COX-2 has also been detected in cultured activity of COX-2 is induced by inflammatory cytokines and cyclo-oxygenases catalyse the synthesis of smooth muscle cells after stimulation with interleukin-1, tumour necrosis factor-, interferon-, and bacterial thromboxane, e.g. TXA 2 , leading to vasoconstriction and platelet aggregation. DNA synthesis in smooth muscle cells 31 and it is therefore possible that COX-2 activity in vascular smooth muscle cells and macrophages may result in an autocrine or paracrine growth-promoting loop. Furthermore, the COX-2 products, PGE 2 and PGI 2 , may reduce cholesterol accumulation by inhibiting neutral cholesterol ester hydrolase and other cholesteryl ester cycle enzymes 10 and in the case of PGI 2 inhibit platelet adhesion to the arterial wall.
11 Finally, they may regulate the expression of proinflammatory cytokines in the plaque by a negative feedback loop.
10
The precise consequences of COX-2 expression depend not only on the presence of the enzyme but also on the substrate availability, i.e. the release of activation, availability of archidonic acid, expression of COX-2, downstream formation of eicosanoids may differ depending on the microenvironment and may demonstrated in human saphenous veins and mamresult in the synthesis of different levels and different mary arteries after stimulation with interleukin-1. 27 In species of prostaglandins. It may therefore be neceshuman cerebral arteries COX-2 expression has been sary to carry out blocking experiments before the shown after cerebral ischaemia, indicating a role for consequences of COX-2 expression can be predicted. COX-2 in ischaemic injury in the human brain.
30
ASA has a documented preventive effect against The present study shows that COX-2 is expressed complications and symptoms in cardiovascular disin smooth muscle cells of the intimal layer of the ease. 19, 20 This effect may be due to dual effects: inhuman artery in atherosclerosis. The simultaneous hibition of COX-1 in platelets preventing platelet expression of proinflammatory cytokines in atheroaggregation and an anti-inflammatory effect by insclerotic lesions suggests that these factors may induce hibiting COX-2. It is tempting to speculate that in-COX-2 expression. The functional role of COX-2 achibition of an inflammatory reaction induced by COXtivity is less obvious. However, several interesting 2 could be of importance to prevent the development possibilities arise from cell biological studies. Thus, prostaglandins, at picomolar concentrations, induce of atherosclerosis. Inhibition of COX-1, on the other 
